BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for June 2019
Rafael Zaklad went from a two-year prognosis to having a non-detectable PSA. Research and medicine funded by the Prostate Cancer Foundation have continued to keep Rafael alive and well. When...Read More
We all hate cancer, but not all of us can afford to whip out our wallets or write a fat check to help fight the disease. But there is no...Read More
“I wanted to give him confidence, I wanted him to believe he could live on. I knew right there, I just knew I needed to help him. Did I know...Read More
If you follow baseball, or if you follow PCF, you have likely heard about the Home Run Challenge. But what is the Home Run Challenge? Here is everything you need...Read More